Flu (Influenza) Vaccine Market, Global Outlook and Forecast 2023-2030
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
This report aims to provide a comprehensive presentation of the global market for Flu (Influenza) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu (Influenza) Vaccine. This report contains market size and forecasts of Flu (Influenza) Vaccine in global, including the following market information:
Global Flu (Influenza) Vaccine Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Flu (Influenza) Vaccine Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Flu (Influenza) Vaccine companies in 2022 (%)
The global Flu (Influenza) Vaccine market was valued at US$ 5664.4 million in 2022 and is projected to reach US$ 7180 million by 2029, at a CAGR of 3.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
We surveyed the Flu (Influenza) Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Flu (Influenza) Vaccine Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Flu (Influenza) Vaccine Market Segment Percentages, by Type, 2022 (%)
Split Influenza Vaccine
Pandemic Influenza Vaccine
Subunit Influenza Vaccine
Quadrivalent Influenza Vaccine
Global Flu (Influenza) Vaccine Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Flu (Influenza) Vaccine Market Segment Percentages, by Application, 2022 (%)
For Children (6 months to 3 years)
For Adults and Children over 3 years
Global Flu (Influenza) Vaccine Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Flu (Influenza) Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Flu (Influenza) Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Flu (Influenza) Vaccine revenues share in global market, 2022 (%)
Key companies Flu (Influenza) Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Flu (Influenza) Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hualan Bio
CCBIO
Aleph Biomedical
SANOFI
Adimmune
ZYAK
SINOVAC
Changsheng Biological
SIOBP
GSK
Aimei Hissen
Tianyuan Bio-pharma(Novartis)
Simcere Vaxtec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Flu (Influenza) Vaccine, market overview.
Chapter 2: Global Flu (Influenza) Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Flu (Influenza) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Flu (Influenza) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Flu (Influenza) Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
